Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 17041657 | LICE ELIMINATOR | January 2021 | August 2024 | Abandon | 47 | 1 | 1 | Yes | No |
| 17118824 | ENTERIC COATED TABLET | December 2020 | December 2023 | Abandon | 36 | 2 | 1 | Yes | No |
| 17055046 | BONE REGENERATION IN COMPROMISED WOUNDS | November 2020 | June 2025 | Allow | 55 | 2 | 1 | Yes | No |
| 17093214 | COMPOSITIONS I - I AND PRODUCTS AND USES THEREOF | November 2020 | December 2023 | Allow | 37 | 2 | 1 | Yes | No |
| 17050063 | IMPLANTABLE DEVICE COMPRISING A TEXTILE COMPONENT COMPRISING MULTIFILAMENT YARNS AND/OR SPUN YARNS MADE OF FIBERS COMPLETELY OR PARTIALLY COATED IN CYCLODEXTRIN POLYMER | October 2020 | June 2025 | Abandon | 56 | 4 | 1 | Yes | No |
| 17070914 | ANTI-INFECTIVE ANTIMICROBIAL-CONTAINING BIOMATERIALS | October 2020 | July 2023 | Abandon | 60 | 2 | 1 | No | No |
| 17047304 | STIFF AND STRONG HYDROGELS, PRODUCTION METHOD AND USES THEREOF | October 2020 | March 2024 | Allow | 41 | 3 | 1 | Yes | No |
| 17039531 | TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH ANTI-PROLIFERATE AND ANTI-INFLAMMATORY DRUGS | September 2020 | August 2022 | Allow | 23 | 1 | 1 | Yes | No |
| 17043255 | OPHTHALMIC DRUG SUSTAINED RELEASE FORMULATION AND USES FOR DRY EYE SYNDROME TREATMENT | September 2020 | November 2022 | Abandon | 25 | 1 | 1 | No | No |
| 16979638 | PROCESS FOR CONDITIONING OF KERATIN FIBERS | September 2020 | November 2024 | Abandon | 50 | 2 | 1 | No | No |
| 16965434 | FILMS AND COMPOSITES AND METHODS OF PRODUCTION AND USE | July 2020 | November 2023 | Abandon | 39 | 3 | 1 | No | No |
| 16938198 | Pre-Mixed, Ready-To-Use Pharmaceutical Compositions | July 2020 | September 2022 | Allow | 25 | 2 | 0 | Yes | No |
| 16963543 | Patch Containing Nonylic Acid Vanillylamide | July 2020 | April 2022 | Allow | 21 | 1 | 0 | Yes | No |
| 16963043 | COMPOSITIONS AND METHODS FOR DELIVERING PHARMACEUTICAL AGENTS | July 2020 | October 2023 | Allow | 39 | 3 | 1 | Yes | No |
| 16962477 | TISSUE-ADAPTIVE MATERIALS | July 2020 | June 2023 | Abandon | 35 | 2 | 1 | No | No |
| 16947002 | TOPICAL SUNSCREEN | July 2020 | February 2025 | Allow | 55 | 5 | 1 | No | No |
| 16913533 | POROUS SILICA MATERIAL FOR USE AS A PHARMACEUTICAL OR DIETARY ACTIVE INGREDIENT | June 2020 | August 2024 | Allow | 49 | 4 | 1 | Yes | No |
| 16957029 | DRUG-LOADED IMPLANTED MEDICAL DEVICE AND PREPARATION METHOD THEREFOR | June 2020 | October 2023 | Abandon | 40 | 3 | 1 | No | No |
| 16768103 | PREVENTION OF THE OXIDATION OF PERFUMERY RAW MATERIALS | May 2020 | May 2024 | Abandon | 47 | 4 | 1 | No | No |
| 16763493 | INSECT REPELLENT COMPOSITIONS AND METHODS OF USE | May 2020 | April 2022 | Abandon | 23 | 1 | 1 | No | No |
| 16763434 | APPLICATION OF PHARMACEUTICAL COMPOSITION IN REGULATION OF FIBROBLAST GROWTH | May 2020 | February 2025 | Abandon | 58 | 6 | 1 | No | No |
| 16839353 | METHOD FOR PROVIDING CONTRACEPTION | April 2020 | April 2022 | Abandon | 25 | 3 | 0 | No | No |
| 16649153 | Vanadyl and vanadate for use in reducing stress-induced metabolic derangement | March 2020 | February 2023 | Abandon | 35 | 3 | 1 | No | No |
| 16821233 | Anti-Blue Light Dermal Topical Composition and Applications Thereof | March 2020 | November 2021 | Abandon | 20 | 1 | 1 | No | No |
| 16816362 | Topical Phospholipid Formulations and Methods for Preparing the Same | March 2020 | January 2024 | Abandon | 46 | 4 | 1 | No | No |
| 16646113 | TOPICAL COMPOSITIONS | March 2020 | May 2023 | Abandon | 38 | 3 | 1 | No | No |
| 16794988 | DIETARY SUPPLEMENTATION WITH MIXED ALKALI SALTS | February 2020 | October 2021 | Allow | 20 | 2 | 1 | Yes | No |
| 16782628 | Systems and Methods for Preservative Removal from Ophthalmic Formulations Comprising Complexing Agents | February 2020 | February 2024 | Abandon | 48 | 2 | 1 | No | No |
| 16635243 | ANTIMICROBIAL COATING MATERIAL COMPRISING NANOCRYSTALLINE CELLULOSE AND MAGNESIUM OXIDE AND METHOD OF PREPARATION THEREOF | January 2020 | March 2022 | Abandon | 26 | 2 | 1 | No | No |
| 16744832 | AQUEOUS COSMETIC COMPOSITION COMPRISING ALKYLCELLULOSE | January 2020 | February 2024 | Abandon | 49 | 3 | 1 | No | Yes |
| 16726813 | NANO-OXIDE/KAOLIN COMPOSITE HEMOSTATIC ANTIBACTERIAL MATERIAL, HEMOSTATIC HEALING-PROMOTING DRESSING AND PREPARATION METHOD THEREOF | December 2019 | February 2022 | Abandon | 26 | 2 | 1 | No | No |
| 16698063 | ISOTRETINOIN ORAL-MUCOSAL FORMULATIONS AND METHODS FOR USING SAME | November 2019 | August 2020 | Allow | 9 | 1 | 0 | Yes | No |
| 16685440 | FORMULATIONS AND USES OF RETINOIC ACID RECEPTOR SELECTIVE AGONISTS | November 2019 | March 2021 | Abandon | 16 | 0 | 1 | No | No |
| 16683963 | MAGNETIC LIQUID PARTICLES | November 2019 | April 2024 | Abandon | 53 | 4 | 1 | Yes | No |
| 16611149 | NON-FIBROTIC BIOCOMPATIBLE ELECTRODE AND RELATED METHODS | November 2019 | May 2025 | Abandon | 60 | 4 | 1 | Yes | No |
| 16653883 | REACTIONS TRIGGERED BY COOLING-INDUCED GEL-TO-SOL TRANSITION OF THERMORESPONSIVE POLYMERS | October 2019 | April 2025 | Abandon | 60 | 6 | 1 | Yes | No |
| 16600233 | RESPONSIVE COATINGS FOR HAIR FIBERS | October 2019 | November 2022 | Allow | 37 | 3 | 1 | Yes | No |
| 16500513 | BODY COSMETIC | October 2019 | December 2022 | Abandon | 38 | 3 | 1 | Yes | No |
| 16552469 | MULTI-LAYER CLEANING AND DISINFECTING WIPES HAVING OPTIMAL DELAMINATION BEHAVIOR WITH CLEANING LOTION | August 2019 | April 2023 | Abandon | 44 | 4 | 1 | No | No |
| 16487519 | SKIN COSMETIC | August 2019 | August 2021 | Abandon | 24 | 1 | 1 | No | No |
| 16480429 | SOLID WATER-IN-OIL COSMETIC EMULSION | July 2019 | October 2020 | Abandon | 15 | 0 | 1 | No | No |
| 16476109 | ULTRAVIOLET-SHIELDING PARTICLE COATED WITH SILICON OXIDE, AQUEOUS COMPOSITION CONTAINING ULTRAVIOLET-SHIELDING PARTICLE COATED WITH SILICON OXIDE, AND COSMETIC | July 2019 | August 2021 | Allow | 25 | 2 | 1 | Yes | No |
| 16456601 | IMPLANTABLE DEVICE FOR THE DELIVERY OF OCTREOTIDE AND METHODS OF USE THEREOF | June 2019 | March 2021 | Abandon | 21 | 1 | 0 | No | No |
| 16474273 | COSMETIC COMPOSITION WITH UNIVERSAL OPTICAL CORRECTION | June 2019 | February 2024 | Abandon | 56 | 4 | 1 | Yes | Yes |
| 16474049 | CERIA NANOCOMPOSITE FOR BIOMEDICAL TREATMENT AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | June 2019 | November 2021 | Allow | 29 | 2 | 1 | Yes | No |
| 16449856 | Production Process For Nsaid-Containing Lozenges, Their Compositions, Their Medicinal Use | June 2019 | October 2020 | Allow | 16 | 0 | 1 | Yes | No |
| 16471793 | SOLID COSMETIC COMPOSITION COMPRISING A SILICONE POLYAMIDE, A SILICONE RESIN AND A DISPERSED AQUEOUS PHASE | June 2019 | July 2023 | Allow | 49 | 5 | 1 | Yes | No |
| 16441844 | COMPOSITION, ARTIFICIAL NAIL COMPOSITION, NAIL DECORATION MATERIAL, ARTIFICIAL NAIL, STORED CONTAINER, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | June 2019 | September 2022 | Allow | 39 | 4 | 1 | Yes | No |
| 16470188 | A MEDICAL IMPLANT AND A METHOD OF COATING A MEDICAL IMPLANT | June 2019 | June 2021 | Abandon | 24 | 1 | 1 | No | No |
| 16468023 | TEXTURED COMPOSITIONS | June 2019 | September 2021 | Abandon | 27 | 2 | 1 | No | No |
| 16427604 | METHOD FOR COATING IMPLANT WITH ACTIVE PHARMACEUTICAL INGREDIENTS | May 2019 | December 2020 | Abandon | 19 | 1 | 1 | No | No |
| 16408903 | METHOD FOR DELIVERY OF BIOLOGIC AGENTS FROM A TOPICAL FORMULATION | May 2019 | June 2021 | Abandon | 26 | 1 | 1 | No | No |
| 16342043 | SKIN COSMETICS | April 2019 | July 2021 | Abandon | 27 | 2 | 1 | Yes | No |
| 16338003 | METHOD OF TREATING A MATERIAL WITH AN AMINE SALT OF A CARBOXYLIC ACID | March 2019 | December 2022 | Abandon | 45 | 4 | 1 | No | No |
| 16337540 | METHODS, COMPOSITIONS AND USES RELATING THERETO | March 2019 | November 2021 | Allow | 31 | 2 | 1 | Yes | No |
| 16337459 | METHODS, COMPOSITIONS AND USES RELATING THERETO | March 2019 | August 2022 | Abandon | 40 | 4 | 1 | Yes | No |
| 16337248 | FILM-FORMING COMPOSITION FOR SKIN OR HAIR COATING | March 2019 | February 2022 | Abandon | 35 | 3 | 1 | No | No |
| 16337222 | METHODS, COMPOSITIONS AND USES RELATING THERETO | March 2019 | May 2022 | Allow | 38 | 3 | 2 | Yes | No |
| 16356393 | Topical Phospholipid Formulations and Methods for Preparing the Same | March 2019 | December 2023 | Abandon | 57 | 6 | 1 | No | No |
| 16288488 | CLEANSING AND CONDITIONING COMPOSITION FOR KERATIN FIBERS, METHOD, USE, AND KIT-OF-PARTS THEREOF | February 2019 | April 2021 | Abandon | 25 | 2 | 1 | Yes | No |
| 16285883 | APERTURED HYDROGEL COMPOSITIONS AND WOUND DRESSINGS | February 2019 | April 2022 | Abandon | 37 | 3 | 1 | No | No |
| 16282593 | ANTIBIOTIC COATING | February 2019 | January 2021 | Abandon | 22 | 2 | 1 | No | No |
| 16273183 | CONSUMER PRODUCT COMPOSITIONS COMPRISING MICROCAPSULES | February 2019 | November 2020 | Abandon | 21 | 1 | 1 | No | No |
| 16321373 | COSMETIC PRODUCT FOR THE LIPS IN THE FORM OF A WATER-IN-OIL EMULSION AND MAKEUP METHOD | January 2019 | November 2024 | Abandon | 60 | 6 | 1 | No | No |
| 16308756 | ABSORBENT ALIPHATIC POLYURETHANE FOAM PRODUCT | December 2018 | February 2023 | Allow | 50 | 4 | 1 | Yes | No |
| 16213630 | COMPOSITIONS I - I AND PRODUCTS AND USES THEREOF | December 2018 | January 2021 | Abandon | 25 | 1 | 1 | Yes | No |
| 16190893 | MICROSPHERICAL PARTICLE | November 2018 | January 2022 | Abandon | 38 | 3 | 1 | No | No |
| 16300116 | TRANSDERMAL FORMULATIONS FOR DELIVERY OF CELECOXIB AND ITS USE IN THE TREATMENT OF CELECOXIB-RESPONSIVE DISEASES AND CONDITIONS | November 2018 | September 2020 | Abandon | 22 | 1 | 1 | No | No |
| 16300513 | COMPOSITIONS COMPRISING POLYESTERS OF BIOLOGICAL ORIGIN AND BIOCOMPATIBLE INORGANIC COMPOUNDS, AND USES THEREOF IN THE COSMETIC FIELD | November 2018 | December 2023 | Abandon | 60 | 4 | 1 | No | Yes |
| 16165033 | COMPACT AEROSOL HAIR CARE COMPOSITION COMPRISING HYDROCARBON FOAMING AGENT | October 2018 | November 2021 | Abandon | 37 | 3 | 1 | Yes | No |
| 16165044 | COMPACT AEROSOL HAIR CARE COMPOSITION COMPRISING HYDROCARBON FOAMING AGENT | October 2018 | July 2023 | Abandon | 57 | 6 | 1 | Yes | No |
| 16159819 | ANTI-MICROBIAL COMPOSITIONS, PREPARATIONS, METHODS, AND USES | October 2018 | July 2020 | Abandon | 21 | 1 | 0 | No | No |
| 16089013 | IMPROVEMENTS IN STENTS FOR THE RELEASE OF ACTIVE PRINCIPLES | September 2018 | June 2022 | Abandon | 44 | 4 | 1 | No | No |
| 16139363 | TOPICAL COMPOSITION AND METHOD FOR TREATING AND PREVENTING ATOPIC DERMATITIS AND INFECTIONS RELATED TO BACTERIA BIOFILM | September 2018 | September 2021 | Allow | 36 | 3 | 1 | Yes | No |
| 16136377 | ENTERIC COATED TABLET | September 2018 | March 2021 | Abandon | 30 | 2 | 1 | No | No |
| 16131063 | SUTURABLE WOVEN IMPLANTS FROM ELECTROSPUN YARNS FOR SUSTAINED DRUG RELEASE IN BODY CAVITIES | September 2018 | August 2023 | Abandon | 59 | 6 | 1 | Yes | No |
| 16083794 | PARTIALLY DEGRADABLE STENTS FOR CONTROLLED REDUCTION OF INTRAOCULAR PRESSURE | September 2018 | January 2025 | Abandon | 60 | 8 | 1 | Yes | No |
| 16110156 | ABUSE DETERRENT SOFT CHEWABLE DRUG FORMULATIONS | August 2018 | January 2021 | Abandon | 28 | 2 | 1 | No | No |
| 16108886 | Dietary Supplementation with Mixed Alkali Salts | August 2018 | February 2021 | Allow | 30 | 3 | 1 | Yes | No |
| 16106930 | MEDICAL BALLOONS WITH NANOPLATELET COMPOSITE MATERIALS AND METHOD OF MAKING THE SAME | August 2018 | October 2020 | Abandon | 25 | 2 | 1 | No | No |
| 16074993 | AQUEOUS EMULSION POLYMERS AS RHEOLOGY MODIFIERS, COMPOSITIONS THEREOF, AND METHOD OF USE | August 2018 | January 2021 | Abandon | 30 | 2 | 1 | No | No |
| 16072593 | TENSING AND/OR FILM-FORMING COSMETIC AGENT CONSISTING OF GALACTOMANNANS AND CROSS-LINKED SULPHATED GALACTANS | July 2018 | July 2023 | Allow | 60 | 5 | 1 | Yes | No |
| 16039630 | DRY BIOCELLULOSE MATERIAL AND PREPARATION THEREOF | July 2018 | January 2020 | Abandon | 18 | 1 | 1 | No | No |
| 16030209 | CONTROLLED RELEASE NUTRIENTS BY COATING | July 2018 | January 2023 | Abandon | 55 | 3 | 1 | No | No |
| 16015806 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE LAMBDA-CARRAGEENAN POLYSACCHARIDE IN COMBINATION WITH AT LEAST ONE SPECIFIC POLYOL, AND PROCESS FOR COSMETIC TREATMENT OF KERATIN FIBERS WITH THE COMPOSITION, AND USE OF THE COMPOSITION FOR HAIR CARE | June 2018 | June 2019 | Abandon | 12 | 0 | 1 | No | No |
| 16065143 | HYDROPHOBICALLY MODIFIED ALKALI-SWELLABLE EMULSION POLYMERS | June 2018 | January 2021 | Abandon | 30 | 2 | 1 | No | No |
| 16064753 | SALICYLIC ACID DERIVATIVE, METHOD FOR PREPARING SAME, AND COSMETIC COMPOSITION FOR WHITENING COMPRISING SAME | June 2018 | October 2020 | Abandon | 28 | 3 | 1 | No | No |
| 16010898 | Pre-Mixed, Ready-To-Use Pharmaceutical Compositions | June 2018 | April 2020 | Allow | 22 | 2 | 1 | Yes | No |
| 15781708 | SOFT GELATIN CAPSULES WITH pH-INDEPENDENT RELEASE | June 2018 | December 2021 | Allow | 42 | 5 | 1 | Yes | No |
| 15781913 | NANOPARTICLE-AQUEOUS DISPERSION LIQUID OF GLYCOSPHINGOLIPID | June 2018 | December 2019 | Abandon | 18 | 0 | 1 | No | No |
| 15993020 | POLYMERIC MESH WITH SELECTIVE PERMEABILITY, FOR THE REPAIR AND REGENERATION OF TISSUES | May 2018 | March 2021 | Abandon | 34 | 4 | 0 | No | No |
| 15992506 | Delivery Particles | May 2018 | August 2020 | Abandon | 27 | 2 | 1 | No | No |
| 15780114 | A HAIR CARE COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | May 2018 | November 2021 | Abandon | 41 | 2 | 1 | No | No |
| 15779898 | A HAIR CARE COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | May 2018 | October 2019 | Abandon | 17 | 1 | 1 | No | No |
| 15779840 | ANTI-UV EMULSIONS STABILIZED WITH LIGNIN AND NANOPARTICLES | May 2018 | November 2021 | Abandon | 42 | 4 | 1 | No | No |
| 15986951 | STACKED BODY AND SHEET FOR APPLICATION TO SKIN | May 2018 | February 2020 | Abandon | 21 | 2 | 1 | Yes | No |
| 15986906 | FIBER ASSEMBLY AND METHOD FOR MANUFACTURING THE SAME | May 2018 | February 2020 | Abandon | 21 | 2 | 1 | Yes | No |
| 15766523 | FILM FORMING AGENT, AND COSMETIC COMPOSITION AND COSMETIC USING SAME | April 2018 | January 2022 | Abandon | 46 | 4 | 1 | Yes | No |
| 15939045 | IMPLANTABLE DEVICES FOR TREATING HIV | March 2018 | March 2022 | Abandon | 48 | 4 | 2 | Yes | No |
| 15760534 | ALCOHOL-BASED SKIN SANITIZER HAVING MICROBICIDAL PROPERTIES | March 2018 | August 2021 | Abandon | 42 | 3 | 1 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BECKHARDT, LYNDSEY MARIE.
With a 18.5% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 18.1% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner BECKHARDT, LYNDSEY MARIE works in Art Unit 1613 and has examined 498 patent applications in our dataset. With an allowance rate of 28.1%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 41 months.
Examiner BECKHARDT, LYNDSEY MARIE's allowance rate of 28.1% places them in the 4% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by BECKHARDT, LYNDSEY MARIE receive 2.80 office actions before reaching final disposition. This places the examiner in the 78% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by BECKHARDT, LYNDSEY MARIE is 41 months. This places the examiner in the 20% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +49.6% benefit to allowance rate for applications examined by BECKHARDT, LYNDSEY MARIE. This interview benefit is in the 92% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 11.6% of applications are subsequently allowed. This success rate is in the 8% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 18.6% of cases where such amendments are filed. This entry rate is in the 24% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 20.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 27% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.
This examiner withdraws rejections or reopens prosecution in 51.8% of appeals filed. This is in the 23% percentile among all examiners. Of these withdrawals, 44.8% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 60.6% are granted (fully or in part). This grant rate is in the 63% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 0.2% of allowed cases (in the 51% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).
Quayle Actions: This examiner issues Ex Parte Quayle actions in 1.4% of allowed cases (in the 67% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.